Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women

William W. Andrews, Baha M. Sibai, Elizabeth A. Thom, Donald Dudley, J. M. Ernest, Donald McNellis, Kenneth J. Leveno, Ronald Wapner, Atef Moawad, Mary J. O'Sullivan, Steve N. Caritis, Jay D. Iams, Oded Langer, Menachem Miodovnik, Mitchell Dombrowski

Research output: Contribution to journalArticle

100 Scopus citations

Abstract

To estimate whether antibiotic treatment of asymptomatic women with a positive cervical or vaginal fetal fibronectin test in the second trimester would reduce the risk of spontaneous preterm delivery.

Original languageEnglish (US)
Pages (from-to)847-855
Number of pages9
JournalObstetrics and gynecology
Volume101
Issue number5
DOIs
StatePublished - May 2003

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women'. Together they form a unique fingerprint.

  • Cite this

    Andrews, W. W., Sibai, B. M., Thom, E. A., Dudley, D., Ernest, J. M., McNellis, D., Leveno, K. J., Wapner, R., Moawad, A., O'Sullivan, M. J., Caritis, S. N., Iams, J. D., Langer, O., Miodovnik, M., & Dombrowski, M. (2003). Randomized clinical trial of metronidazole plus erythromycin to prevent spontaneous preterm delivery in fetal fibronectin-positive women. Obstetrics and gynecology, 101(5), 847-855. https://doi.org/10.1016/s0029-7844(03)00172-8